Literature DB >> 10679503

Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction.

H Nakane1, F J Miller, F M Faraci, K Toyoda, D D Heistad.   

Abstract

Angiotensin II stimulates vascular NADPH oxidase to produce superoxide, which can react with nitric oxide and impair vasomotor function. We tested the hypothesis that the overexpression of endothelial nitric oxide synthase (eNOS) or superoxide dismutase (SOD) would correct angiotensin II-induced endothelial dysfunction. We examined the effects of the gene transfer of eNOS or 2 isoforms of SOD to the aorta in angiotensin II-treated rabbits on vasomotor function. New Zealand White rabbits were treated for 1 week with angiotensin II (100 ng. kg(-1). min(-1)) or saline by osmotic minipumps. In angiotensin II-treated rabbits, mean blood pressure was 107+/-8 mm Hg; it was 67+/-5 mm Hg in saline-infused rabbits (P<0.05). In aortas from angiotensin II-treated rabbits, lucigenin-enhanced chemiluminescence demonstrated a 2.5-fold increase in superoxide levels, and the oxidative fluorescent probe hydroethidine indicated increased superoxide levels throughout the vascular wall, especially in the endothelium and adventitia. Maximal relaxation to acetylcholine was less in aortas from rabbits treated with angiotensin II (72+/-5% versus 87+/-4% in saline-treated rabbits; P<0.01), but responses to sodium nitroprusside were similar. Segments of the thoracic aorta were incubated in vitro with an adenoviral vector that expressed eNOS, copper zinc SOD (CuZnSOD), extracellular SOD (ECSOD), or beta-galactosidase. beta-Gal treatment with adenovirus containing the gene for eNOS (AdeNOS) but not adenovirus containing the gene for beta-gal (Adbeta-gal) (control virus) restored responses to acetylcholine (82+/-3% after AdeNOS and 67+/-4% after Adbeta-gal). Gene transfer of CuZnSOD or ECSOD did not improve the endothelium-dependent relaxation of the aorta in rabbits that received angiotensin II. Thus, gene transfer of eNOS, but not SOD, effectively restores vasomotor function in angiotensin II-infused rabbits.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679503     DOI: 10.1161/01.hyp.35.2.595

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.

Authors:  Maria A Potenza; Sara Gagliardi; Leonarda De Benedictis; Addolorata Zigrino; Edy Tiravanti; Giuseppe Colantuono; Antonio Federici; Loredana Lorusso; Vincenzo Benagiano; Michael J Quon; Monica Montagnani
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

Review 2.  Genetic targeting of the renin-angiotensin system for long-term control of hypertension.

Authors:  Beverly L Metcalfe; Mohan Raizada; Michael J Katovich
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

3.  Effects of a common human gene variant of extracellular superoxide dismutase on endothelial function after endotoxin in mice.

Authors:  Donald D Lund; Yi Chu; Robert M Brooks; Frank M Faraci; Donald D Heistad
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

Review 4.  NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?

Authors:  L Van Heerebeek; C Meischl; W Stooker; C J L M Meijer; H W M Niessen; D Roos
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

Review 5.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 6.  The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases.

Authors:  Angelino Calderone
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

Review 7.  NADPH oxidases in vascular pathology.

Authors:  Anna Konior; Agata Schramm; Marta Czesnikiewicz-Guzik; Tomasz J Guzik
Journal:  Antioxid Redox Signal       Date:  2013-11-01       Impact factor: 8.401

8.  Extracellular but not cytosolic superoxide dismutase protects against oxidant-mediated endothelial dysfunction.

Authors:  Erin L Foresman; Francis J Miller
Journal:  Redox Biol       Date:  2013-05-24       Impact factor: 11.799

9.  Expression of eNOS in kidneys from hypertensive patients.

Authors:  Xin Gu; Guillermo A Herrera
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-03-09

Review 10.  The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.

Authors:  Inés Roger; Javier Milara; Paula Montero; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.